(19)
(11) EP 3 353 205 A1

(12)

(43) Date of publication:
01.08.2018 Bulletin 2018/31

(21) Application number: 16791529.7

(22) Date of filing: 23.09.2016
(51) International Patent Classification (IPC): 
C07K 16/26(2006.01)
(86) International application number:
PCT/EP2016/072704
(87) International publication number:
WO 2017/050974 (30.03.2017 Gazette 2017/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 25.09.2015 EP 15306492

(71) Applicants:
  • INSERM - Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • Centre National de la Recherche Scientifique (CNRS)
    75016 Paris (FR)
  • Université Paris Diderot - Paris 7
    75013 Paris (FR)
  • Universite Paris-Sud
    91400 Orsay (FR)

(72) Inventors:
  • DI CLEMENTE-BESSE, Nathalie
    75205 Paris Cedex 13 (FR)
  • JOSSO, Nathalie
    92120 Montrouge (FR)
  • CATE, Richard
    75205 Paris Cedex 13 (FR)
  • BELVILLE, Corinne
    92120 Montrouge (FR)

(74) Representative: Collin, Matthieu 
Inserm-Transfert Paris Biopark 7, rue Watt
75013 Paris
75013 Paris (FR)

   


(54) ANTI-MULLERIAN HORMONE (AMH) NEUTRALIZING ANTIBODIES AND USES THEREOF